Astrazeneca reported 20.92B in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Astrazeneca AZN:US 20.92B 1.73B
AstraZeneca AZN:LN 20.92B 1.73B
Bristol Myers Squibb BMY:US $ 30186M 65M
Canopy Growth Corp WEED:CN C$ 1.59B 143.83M
Catalent CTLT:US $ 3025M 51M
Corcept Therapeutics CORT:US $ 419.04M 30.82M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
Genmab GEN:DC 23.18B 439M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Horizon Pharma HZNP:US $ 3203.09M 255.36M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Lannett LCI:US $ 318.7M 15.91M
Novartis NOVN:VX 38.14B 906M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Perrigo Ordinary Shares PRGO:US $ 3935.5M 75.6M
Phibro Animal Health PAHC:US $ 546.48M 37.87M
Prestige Brands PBH:US $ 324.62M 31.35M
Supernus Pharmaceuticals SUPN:US $ 625.12M 56.6M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
Valeant Pharmaceuticals VRX:CN $ 5836M 229M
Zoetis ZTS:US $ 6651M 186M